LigoCyte Pharmaceuticals' Angel - III Round

LigoCyte Pharmaceuticals raised a round of funding on May 14, 2010.

Ligocyte focuses on cellular immunology and new approaches to fight dangerous pathogens. The company's lead programs include vaccines against norovirus, anthrax and influenza.…

Articles about LigoCyte Pharmaceuticals' Angel - III Round: